RE: Wait for Bombastic Urocidin Results ..DollarChamps, thanks for your endorsement.
If Endo is really trying to hit a home run with Urocidin and go after the refractory population. The study has to be designed very carefully. Being close to the end of the year and with all the new acquisitions they have, I am afraid they might not be ready for Urocidin until early 2011. While I have all the confidence in Urocidin, I think the constant call of "news coming any minute" is creating too much expectation that will eventually leads to unnecessary disappointment and impatience which will hurt the stock price. I think the best approach now is lay low. Let the chip falls where they may. Add shares when appropriate and get ready for the big windfall when the time comes.
BTW, what is your screen-name in the Yahoo board?